000 01365 a2200397 4500
005 20250516030736.0
264 0 _c20110824
008 201108s 0 0 eng d
022 _a1600-0609
024 7 _a10.1111/j.1600-0609.2011.01610.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMarchand, Tony
245 0 0 _aCutaneous macroglobulinosis treated with bortezomib and rituximab.
_h[electronic resource]
260 _bEuropean journal of haematology
_cJul 2011
300 _a98 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
_xadministration & dosage
650 0 4 _aBoronic Acids
_xadministration & dosage
650 0 4 _aBortezomib
650 0 4 _aHumans
650 0 4 _aImmunoglobulin M
_xmetabolism
650 0 4 _aMale
650 0 4 _aPyrazines
_xadministration & dosage
650 0 4 _aRecurrence
650 0 4 _aRituximab
650 0 4 _aSkin Diseases
_ximmunology
650 0 4 _aWaldenstrom Macroglobulinemia
_ximmunology
700 1 _aTas, Patrick
700 1 _aHouot, Roch
700 1 _aDauriac, Charles
700 1 _aLamy, Thierry
700 1 _aCahu, Xavier
773 0 _tEuropean journal of haematology
_gvol. 87
_gno. 1
_gp. 98
856 4 0 _uhttps://doi.org/10.1111/j.1600-0609.2011.01610.x
_zAvailable from publisher's website
999 _c20688625
_d20688625